G0S2 and central nervous system cancer: To verify the role of G0S2 in glioma malignancy, we measured G0S2 gene expression in WHO grade II diffuse astrocytoma, grade III anaplastic astrocytoma, and grade IV primary GBM tissue samples (Fig 2A).